Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight Loss, Ozempic
I’m a weight-loss doctor — the unusual complication I’m seeing from Ozempic-like drugs
A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like Ozempic.
GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending. But thus far, the data don’t show this.
Ozempic: Beyond Diabetes, A Breakthrough for Weight Loss?
Ozempic: Beyond Diabetes, A Breakthrough for Weight Loss?
A New Ozempic? Researchers Develop New Weight Loss Drug That Doesn't Cause Nausea
The drug's development was funded by Novo Nordisk, the maker of popular semaglutide drugs like Ozempic and Wegovy. While these GLP-1 receptor agonists are effective in weight management, they often come with side effects such as nausea.
Ozempic, Wegovy, and Mounjaro: Your Go-To Guide for Weight Loss with Meds
Everything you need to know about using Ozempic, Wegovy, and Mounjaro to shed those extra pounds. We dive into their perks, potential pitfalls, and why you should always have a doc on board.
8h
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
Medscape
2d
Early Intervention Central to Treating Muscle Mass Loss in Patients Losing Weight With GLP-1 Meds
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
TCTMD
21m
Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
23h
on MSN
Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
JPMorgan's annual survey of 40 executives shows that coverage of popular weight-loss drugs continues to slowly increase ...
Ag Funder News
2d
GLP-1 users’ grocery spending drops, but then levels out after 12 months – Circana data
GLP-1 weight loss users cut food spending in their first 3 months, says Circana. But by the end of year one, spending is ...
6h
on MSN
Terry Smith Sells Diageo Stock on Concern Over Weight-Loss Drugs
British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...
7h
GLP-1 Medications Fuel Growth in Medical Aesthetics, with Weight Loss Accounting for 11% of Non-Surgical Spending in 2024
Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today revealed new ...
1d
on MSN
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
8d
Ozempic and Similar Drugs May Offer Health Benefits Beyond Weight Loss, Including Reduced Alcohol Cravings
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Fierce Healthcare
1d
Found introducing oral dissolvable GLP-1 tablet at reduced price
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
FierceBiotech
2d
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Eli Lilly and Company
Ozempic
Wegovy
Glucagon-like peptide-1
Feedback